Vertebral axial decompression therapy for pain associated with herniated or degenerated discs or facet syndrome: an outcome study.
The outcomes of vertebral axial decompression (VAX-D) therapy for patients with low back pain from various causes are reported. Data was collected from twenty-two medical centers for patients who received VAX-D therapy for low back pain, which was sometimes accompanied by referred leg pain. Only patients who received at least ten sessions and had a diagnosis of herniated disc, degenerative disc, or facet syndrome, which were confirmed by diagnostic imaging, were included in this study; a total of 778 cases. The average time between the initial onset of symptoms and the beginning of this therapy was 40 months, and it was four months or more in 83% of the cases. The data contained the patients' quantitative assessments of their own pain, mobility, and ability to carry out the usual 'activities of daily living'. The treatment was successful in 71% of the 778 cases, when success was defined as a reduction in pain to 0 or 1, on a 0 to 5 scale. Improvements in mobility and activities of daily living correlated strongly with pain reduction. The causes of back pain and their relationship to this therapy are also discussed.
Gose
E E
EE
Department of Bioengineering, University of Illinois at Chicago, USA.
Naguszewski
W K
WK
Naguszewski
R K
RK
D005947:Glucose / Q000378:metabolism; D006801:Humans; D007403:Intervertebral Disc / Q000378:metabolism / Q000473:pathology; D007405:Intervertebral Disc Displacement / Q000150:complications*; D017116:Low Back Pain / Q000209:etiology* / Q000628:therapy*; D010147:Pain Measurement; D011312:Pressure; D014143:Traction; D016896:Treatment Outcome; D014867:Water / Q000378:metabolism
D014867:Water; D005947:Glucose